| Excerpt | Relevance | Reference |
|---|
| "In this prospective, factorial, randomized, multicenter trial, we compared cyclo-oxygenase-2 inhibitor (celecoxib) with placebo and diode grid laser with standard Early Treatment Diabetic Retinopathy Study focal laser treatment in 86 participants with diabetic macular edema." | 9.14 | Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema. ( Aiello, LP; Avery, R; Callanan, D; Chew, EY; Coleman, HR; Ferris, FL; Figueroa, M; Fish, G; Haller, JA; Hammel, K; Ip, M; Kim, J; Martin, D; Thompson, DJ, 2010) |
| "In this prospective, factorial, randomized, multicenter trial, we compared cyclo-oxygenase-2 inhibitor (celecoxib) with placebo and diode grid laser with standard Early Treatment Diabetic Retinopathy Study focal laser treatment in 86 participants with diabetic macular edema." | 5.14 | Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema. ( Aiello, LP; Avery, R; Callanan, D; Chew, EY; Coleman, HR; Ferris, FL; Figueroa, M; Fish, G; Haller, JA; Hammel, K; Ip, M; Kim, J; Martin, D; Thompson, DJ, 2010) |